BELLUS HEALTH INC (BLU) Forecast, Price Target & Analyst Ratings

NASDAQ:BLU • CA07987C2040

14.74 USD

0 (0%)

At close: Jun 28, 2023

14.74 USD

0 (0%)

After Hours: 6/28/2023, 8:00:02 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BELLUS HEALTH INC (BLU).

Consensus Price Target

Price Target

$15.39

+ 4.44% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Aug 8, 2023
Period: Q2 / 2023
EPS Estimate: -$0.23
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

76.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$15.39

Upside

+ 4.44%

From current price of $14.74 to mean target of $15.39, Based on 10 analyst forecasts

Low

$13.39

Median

$15.02

High

$18.56

Price Target Revisions

1 Month

0.00%

3 Months

12.96%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for BLU. The average price target is 15.39 USD. This implies a price increase of 4.44% is expected in the next year compared to the current price of 14.74.

The average price target has been revised upward by 12.96% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

76.00%

BLU was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BLU.

In the previous month the buy percentage consensus was at a similar level.

BLU was analyzed by 10 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2023-05-15	RBC Capital	Reiterate	Sector Perform -> Sector Perform
2023-04-19	RBC Capital	Downgrade	Outperform -> Sector Perform
2023-04-19	Jefferies	Downgrade	Buy -> Hold
2023-04-18	Evercore ISI Group	Downgrade	Outperform -> In-Line
2023-03-22	RBC Capital	Reiterate	Outperform
2023-03-22	HC Wainwright & Co.	Reiterate	Buy
2022-09-30	RBC Capital	Maintains	Outperform
2022-09-23	Jefferies	Maintains	Buy
2022-08-11	HC Wainwright & Co.	Maintains	Buy
2022-07-13	RBC Capital	Maintains	Outperform
2022-02-24	HC Wainwright & Co.	Maintains	Buy
2021-12-13	Evercore ISI Group	Maintains	Outperform
2021-12-07	RBC Capital	Maintains	Outperform
2021-10-18	RBC Capital	Maintains	Outperform
2021-09-14	HC Wainwright & Co.	Maintains	Buy
2021-08-12	RBC Capital	Initiate	Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date: Aug 8, 2023
Period: Q2 / 2023
EPS Estimate: -$0.23
Revenue Estimate
Revenue Q2Q: -100.00%
EPS Q2Q: -26.25%
Number of Analysts: 3

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

-100.00%

EPS (1 Month)

0.00%

EPS (3 Months)

-22.73%

Next Earnings Summary

BLU is expected to report earnings on 8/8/2023. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 0 USD.

The next earnings revenue estimate has been revised downward by 100% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	20K -33.33%	16K -20.00%	16K	11.868K -25.83%	11.868K	2.507M 21,024.92%	126.12M 4,930.71%	453.75M 259.78%	727.96M 60.43%	891.51M 22.47%	1.044B 17.10%
EBITDA YoY % growth	-32.76M -27.92%	-73.091M -123.11%	-77.578M -6.14%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	-32.94M -28.02%	-73.284M -122.48%	-77.883M -6.28%	-101.068M -29.77%	-119.529M -18.27%	-139.189M -16.45%	-66.506M 52.22%	275.56M 514.34%	458.81M 66.50%	590.4M 28.68%	735.04M 24.50%
Operating Margin	-164,700.00%	-458,025.00%	-486,768.75%	-851,634.04%	-1,007,200.00%	-5,552.02%	-52.73%	60.73%	63.03%	66.22%	70.41%
EPS YoY % growth	-0.51 7.10%	-0.90 -76.30%	-0.66 26.63%	-0.84 -27.52%	-0.92 -8.96%	-0.87 4.74%	-0.36 58.62%	1.68 565.77%	2.68 59.06%	3.30 23.26%	3.91 18.47%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q2 / 23	Q3 / 23	Q4 / 23
EPS Q2Q % growth	-0.23 -26.25%	-0.24 -21.20%	-0.26 -75.07%
Revenue Q2Q % growth	-100.00%	-100.00%	-100.00%
EBITDA Q2Q % growth	N/A	N/A	N/A
EBIT Q2Q % growth	-29.184M -63.63%	-30.423M -31.84%	-31.722M -46.37%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

-9.80%

EPS Next 5 Year

35.40%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

413.52%

Revenue Next 5 Year

654.86%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BELLUS HEALTH INC / BLU Forecast FAQ

Can you provide the average price target for BELLUS HEALTH INC stock?

10 analysts have analysed BLU and the average price target is 15.39 USD. This implies a price increase of 4.44% is expected in the next year compared to the current price of 14.74.

When does BELLUS HEALTH INC (BLU) report earnings?

BELLUS HEALTH INC (BLU) will report earnings on 2023-08-08, after the market close.

Can you provide the consensus estimates for BELLUS HEALTH INC next earnings?

The consensus EPS estimate for the next earnings of BELLUS HEALTH INC (BLU) is -0.23 USD and the consensus revenue estimate is 0 USD.

What is the expected long term growth rate for BLU stock?

The expected long term growth rate for BELLUS HEALTH INC (BLU) is 413.52%.

Analyst forecast overview

Forecast Snapshot